James Ballenger to Drug Administration Schedule
This is a "connection" page, showing publications James Ballenger has written about Drug Administration Schedule.
Connection Strength
0.230
-
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42.
Score: 0.033
-
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 8:47-54.
Score: 0.033
-
Sertraline in social phobia. J Clin Psychopharmacol. 1995 Oct; 15(5):372-3.
Score: 0.028
-
Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct; 54 Suppl:15-21; discussion 22-4.
Score: 0.024
-
Medication discontinuation in panic disorder. J Clin Psychiatry. 1992 Mar; 53 Suppl:26-31.
Score: 0.022
-
Fluoxetine treatment of voyeurism. Am J Psychiatry. 1991 Jul; 148(7):950.
Score: 0.021
-
Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry. 1991 Feb; 52 Suppl:18-23; discussion 24-5.
Score: 0.020
-
Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32.
Score: 0.015
-
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
Score: 0.009
-
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8.
Score: 0.008
-
Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995 Oct; 167(4):487-94.
Score: 0.007
-
Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.
Score: 0.006
-
Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992 Oct; 12(5):352-4.
Score: 0.006